Cited in:


This article has been cited by:

  1. 1
    W. Cui, D. Zhang, M. T. Cunningham, L. Tilzer, Leukemia-associated aberrant immunophenotype in patients with acute myeloid leukemia: changes at refractory disease or first relapse and clinicopathological findings, International Journal of Laboratory Hematology, 2014, 36, 6
  2. You have free access to this content2
    Hanne Ø. Larsen, Anne S. Roug, Tom Just, Gordon D. Brown, Peter Hokland, Expression of the hMICL in acute myeloid leukemia—a highly reliable disease marker at diagnosis and during follow-up, Cytometry Part B: Clinical Cytometry, 2012, 82B, 1
  3. 3
    Peter Hokland, Hans Beier Ommen, Charlotte Guldborg Nyvold, Anne Stidsholt Roug, Sensitivity of minimal residual disease in acute myeloid leukaemia in first remission – methodologies in relation to their clinical situation, British Journal of Haematology, 2012, 158, 5
  4. 4
    Minimal Residual Disease,